• Be A Partner
  • Social Responsibility
    • Students Training
  • IR
    • Investor Relations
    • Financial Charts
    • Annual Reports
  • News
    • PRESS RELEASES
    • SOCIAL EVENTS
    • CONFERENCES
  • Careers
  • Covid-19
  • Report a side effect
  • Contact Us
    • Branches
  • Home
  • We are Eipico
    We are Eipico
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Uniqueness
      • WHO Approval
      • Sterile products Area
      • Automatic Ampoules Inspection
      • Eipico Ophthalmology
      • Primary packaging materials
      • Restricted-access barrier system
      • Distribution Channel
    • Our History
    • Vision, Mission & Values
    • Chairman Message
    • Eipico Employees
    • Manufacturing Facilities
    • Media Library
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Eipico Destination
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Factory 1
    • Factory 2
    • Factory 3 (Biotechnology)
    • Eiaco Factory
    • Batterjee Factory
    • EIPICO Plastic Factory
  • R&D And Quality
    R&D And Quality
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Quality Assurance
    • Quality Control
    • R&D
    • Regulatory Affairs
    • Global Accreditation
    • Track and Trace
  • Products
    Products
    EIPICO produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Eipico Products
      • By Alphabet
  • Biotechnology
Global
You are here : >>Global



Global Presence

EIPICO Headquarters was first established at the Heart of the World in Egypt and expanded over the decades to reach people from the far east to the west. 

EIPICO is Globally Present in 65 countries with ambitious strategic plan reaching 100 Countries by 2025. 

Read more


 ► Countries Active In Sales & Marketing 
► Targeted Countries For Marketing      


EIPICO strongly believes that delivering High-Quality Pharmaceutical Products to every Patient at affordable prices is a basic human right. 
We achieve this through:


Commitment 

 

EIPICO’s pursuit of Healthcare Services Expansion Reaching Patients in Low-income Countries is a top priority.



Strategy 

 

EIPICO Serves Patients Worldwide through all business integration models not only by the Collaboration with Local Pharmaceutical Importing and Distributing companies but also through exporting Semifinished Contract Manufacturing Products & Finished Under license Agreement Products.



Diversity 

 

EIPICO exploits its Facilities and Human Capabilities to improve patient’s Quality of life by Covering more than 25 therapeutic disease area and 1300 different product registered worldwide.



Capacity 

 

 -Production Capacity units
 -Operation management & efficiency 





EIPICO manufactures more than 400 Pharmaceutical Products covering 24 Therapeutic Groups. Moreover, we have a keen sense of market dynamics. Thus, always introducing products matching customer needs e.g. Epizithro, Epicare, Gufidrexn & Epicopred.

EIPICO is trusted for its high-quality standards, that’s why EIPICO is producing many products for multinational companies.

EIPICO holds License Agreements with a group of international pharmaceutical companies to produce their products locally.

EIPICO is currently the Largest Provider of Antibiotics, Lyophilized Products and Spansule Capsules to the Egyptian market.


EIPICO produces novel dosage forms, such as Spansule capsules & non-traditional dosage forms, e.g. soft gelatin capsules, lyophilized products, gels, sprayers & effervescent tablets



EIPICO produces many of the Covid-19 related protocol medicines: Epicehin, Epizithro, Cetal, Dexamethasone, Cevitil



EIPICO was awarded the ISO - 9001 for Quality Assurance excellence.



EIPICO is an eco-friendly company & was awarded ISO - 14001 for environmentally friendly practices.



EIPICO captures significant market share in many therapeutic areas

Anti-Infective
CVS system
Analgesics & Anti-inflammatory
Dermatological
Systemic sex hormones
Alimentary, Metabolism
Respiratory system
Ophthalmics


EIPICO has an outstanding Performance in the Egyptian Market



EIPICO is ranked no. 1 in Systemic Anti-Infectives Market by units
(Source: IQVIA, MAT, 09, 20)

EIPICO is ranked no. 1 in Ophthalmics Market by units
(Source: IQVIA, MAT, 09, 20)




Global Accreditation 


EIPICO implements all the quality standards to ensure that its products provide competitive advantages in efficacy, safety and price, worldwide. 

EIPICO premises undergo regular inspections by different foreign health authorities.

EIPICO was certified and recognized as Quality Manufacturer by MHRA UK, PICs, WHO prequalified Lines, GCC, Ukrainian GMP, Romanian GMP, NFDAC, Ugandan GMP, and Ghanaian FDA authorities.


Certifications



   Customized Packaging  


English Packages



French Packages



Romanian Packages



Russian Packages







WE ARE EIPICO

  • Uniqueness
  • Our History
  • Vision, Mission & Values
  • Chairman Message
  • Eipico Employees

Manufacturing Facilities

  • Factory 1
  • Factory 2
  • Factory 3
  • Eiaco Factory
  • Batterjee Factory
  • Plastic Factory

Products

  • Eipico Product
  • Eipico Products By Alphabet

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
    Visitors Count : 864548